417 related articles for article (PubMed ID: 29421776)
1. Association Between Matrix Metalloproteinase-3 Activity and Glomerular Filtration Rate and Albuminuria Status in Patients With Type 2 Diabetes Mellitus.
Amanzadeh M; Mota A; Zarghami N; Abedi-Azar S; Abroon S; Akbarian N; Mihanfar A; Rahmati-Yamchi M
Iran J Kidney Dis; 2018 Jan; 12(1):40-47. PubMed ID: 29421776
[TBL] [Abstract][Full Text] [Related]
2. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH
Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836
[TBL] [Abstract][Full Text] [Related]
3. Albuminuria and reduced glomerular filtration rate for predicting the renal outcomes in type 2 diabetic patients.
Tanaka N; Babazono T; Takagi M; Yoshida N; Toya K; Nyumura I; Hanai K; Uchigata Y
Nephrology (Carlton); 2015 Aug; 20(8):531-8. PubMed ID: 25773273
[TBL] [Abstract][Full Text] [Related]
4. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
Li Z; Xu Y; Liu X; Nie Y; Zhao Z
Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
[TBL] [Abstract][Full Text] [Related]
5. Decline in estimated glomerular filtration rate is associated with risk of end-stage renal disease in type 2 diabetes with macroalbuminuria: an observational study from JDNCS.
Shimizu M; Furuichi K; Toyama T; Funamoto T; Kitajima S; Hara A; Ogawa D; Koya D; Ikeda K; Koshino Y; Kurokawa Y; Abe H; Mori K; Nakayama M; Konishi Y; Samejima KI; Matsui M; Yamauchi H; Gohda T; Fukami K; Nagata D; Yamazaki H; Yuzawa Y; Suzuki Y; Fujimoto S; Maruyama S; Kato S; Naito T; Yoshimura K; Yokoyama H; Wada T;
Clin Exp Nephrol; 2018 Apr; 22(2):377-387. PubMed ID: 28889347
[TBL] [Abstract][Full Text] [Related]
6. Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Rapid eGFR Decline and Albuminuria Progression in Type 2 Diabetes Mellitus.
Liu JJ; Pek SLT; Ang K; Tavintharan S; Lim SC;
J Clin Endocrinol Metab; 2017 Oct; 102(10):3683-3691. PubMed ID: 28973352
[TBL] [Abstract][Full Text] [Related]
7. The estimated glomerular filtration rate is associated with subclinical atherosclerosis, independently of albuminuria, in patients with type 2 diabetes.
Lu B; Wan J; Yang Y; Li Y; Hu R
Int Angiol; 2013 Oct; 32(5):532-9. PubMed ID: 23903314
[TBL] [Abstract][Full Text] [Related]
8. Serum prolactin and macroprolactin levels in diabetic nephropathy.
Sari F; Sari R; Ozdem S; Sarikaya M; Cetinkaya R
Clin Nephrol; 2012 Jul; 78(1):33-9. PubMed ID: 22732335
[TBL] [Abstract][Full Text] [Related]
9. Profibrotic Circulating Proteins and Risk of Early Progressive Renal Decline in Patients With Type 2 Diabetes With and Without Albuminuria.
Ihara K; Skupien J; Kobayashi H; Md Dom ZI; Wilson JM; O'Neil K; Badger HS; Bowsman LM; Satake E; Breyer MD; Duffin KL; Krolewski AS
Diabetes Care; 2020 Nov; 43(11):2760-2767. PubMed ID: 32887710
[TBL] [Abstract][Full Text] [Related]
10. [An association between adiponectin and renal dysfunction in patients with type 2 diabetes mellitus].
Galovičová A; Lazúrová I; Petrášová D
Vnitr Lek; 2012 Nov; 58(11):825-9. PubMed ID: 23256827
[TBL] [Abstract][Full Text] [Related]
11. High frequencies of diabetic micro- and macroangiopathies in patients with type 2 diabetes mellitus with decreased estimated glomerular filtration rate and normoalbuminuria.
Ito H; Takeuchi Y; Ishida H; Antoku S; Abe M; Mifune M; Togane M
Nephrol Dial Transplant; 2010 Apr; 25(4):1161-7. PubMed ID: 19892756
[TBL] [Abstract][Full Text] [Related]
12. Serum Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1 and Matrix Metalloproteinase-9/ Neutrophil Gelatinase-associated Lipocalin Complex Levels in Patients With Early-stage Diabetic Nephropathy.
Cakirca G; Turgut FH
Iran J Kidney Dis; 2018 Oct; 12(5):299-304. PubMed ID: 30367022
[TBL] [Abstract][Full Text] [Related]
13. Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development.
Nowak N; Skupien J; Smiles AM; Yamanouchi M; Niewczas MA; Galecki AT; Duffin KL; Breyer MD; Pullen N; Bonventre JV; Krolewski AS
Kidney Int; 2018 May; 93(5):1198-1206. PubMed ID: 29398132
[TBL] [Abstract][Full Text] [Related]
14. Endocan and albuminuria in type 2 diabetes mellitus.
Cikrikcioglu MA; Erturk Z; Kilic E; Celik K; Ekinci I; Yasin Cetin AI; Ozkan T; Cetin G; Dae SA; Kazancioglu R; Erkoc R
Ren Fail; 2016 Nov; 38(10):1647-1653. PubMed ID: 27756187
[TBL] [Abstract][Full Text] [Related]
15. Improvement in albuminuria in patients with type 2 diabetes after laparoscopic adjustable gastric banding.
Stephenson DT; Jandeleit-Dahm K; Balkau B; Cohen N
Diab Vasc Dis Res; 2013 Nov; 10(6):514-9. PubMed ID: 23975723
[TBL] [Abstract][Full Text] [Related]
16. B-type natriuretic peptide and renal function in Japanese patients with type 2 diabetes mellitus: The Dogo Study.
Furukawa S; Sakai T; Niiya T; Miyaoka H; Miyake T; Yamamoto S; Tanaka K; Ueda T; Senba H; Torisu M; Minami H; Matsuura B; Hiasa Y; Miyake Y
Endocr J; 2017 Dec; 64(12):1131-1136. PubMed ID: 28855437
[TBL] [Abstract][Full Text] [Related]
17. Tocotrienol-Rich Vitamin E from Palm Oil (Tocovid) and Its Effects in Diabetes and Diabetic Nephropathy: A Pilot Phase II Clinical Trial.
Tan SMQ; Chiew Y; Ahmad B; Kadir KA
Nutrients; 2018 Sep; 10(9):. PubMed ID: 30227659
[TBL] [Abstract][Full Text] [Related]
18. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
Shoukry A; Bdeer Sel-A; El-Sokkary RH
Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
[TBL] [Abstract][Full Text] [Related]
19. Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes.
Jeon YK; Kim MR; Huh JE; Mok JY; Song SH; Kim SS; Kim BH; Lee SH; Kim YK; Kim IJ
J Korean Med Sci; 2011 Feb; 26(2):258-63. PubMed ID: 21286018
[TBL] [Abstract][Full Text] [Related]
20. Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus.
Pena MJ; Lambers Heerspink HJ; Hellemons ME; Friedrich T; Dallmann G; Lajer M; Bakker SJ; Gansevoort RT; Rossing P; de Zeeuw D; Roscioni SS
Diabet Med; 2014 Sep; 31(9):1138-47. PubMed ID: 24661264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
